Presentation: Breaking Through the Noise: How Veracyte and UCL Turned Landmark Oncology Data into Global Headlines at ASCO 2026
Wed, Sep 16
|
11:15 AM - 11:40 AM
123
Session details:
- Behind-the-scenes look at the communications strategy for the landmark OPTIMA study and U.S. launch of Veracyte’s Prosigna Breast test at ASCO 2026.
- How Veracyte and University College London navigated embargoes, media exclusives, and complex stakeholder coordination.
- Strategies for breaking through one of healthcare's most competitive news cycles with practice-changing oncology data.
- Lessons on translating complex clinical research into compelling stories for media, patients, clinicians, and investors.
- Key takeaways and best practices for maximizing the impact of major scientific and product announcements.
